Related Experiment Video
Updated: Jun 8, 2026
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
Mapping and ablation outcomes of extra-pulmonary vein triggers in atrial fibrillation: single-centre retrospective
Seunghoon Cho1, Daehoon Kim1, Hanjin Park1
1Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.
Aims:
Extra-pulmonary vein triggers (ExPVTs) are recognized as important contributors to atrial fibrillation (AF) recurrence after radio-frequency catheter ablation (RFCA). This study aimed to investigate the clinical characteristics, diagnostic value, and prognostic implications of isoproterenol-induced ExPVTs in patients undergoing de novo RFCA with circumferential pulmonary vein isolation (CPVI).
Methods And Results:
We analysed 2619 non-valvular AF patients (25.8% female, mean age 59.4 ± 10.9 years, 60.7% with paroxysmal AF) who underwent CPVI and standardized isoproterenol provocation testing; 98.2% also received empirical right atrial (RA) ablation. We evaluated the clinical and prognostic significance of ExPVTs for AF recurrence within 2 years, considering their anatomical location and targeted ablation status. ExPVTs were identified in 13.5% of patients. Lower mean left atrial (LA) voltage was independently associated with ExPVTs, irrespective of sex. Importantly, ExPVTs remained independently associated with AF recurrence [hazard ratio (HR) 1.81 (95% confidence interval 1.39-2.35)], alongside AF type, body mass index, LA volume index, and mean LA voltage as significant predictors. LA [HR 1.50 (1.04-2.17)] and septal [HR 1.51 (1.02-2.23)] triggers were significantly associated with recurrence, while RA triggers were not, given the high rate of empirical RA ablation (98.9%). Recurrence risk was highest in patients with multiple or unmappable triggers and in those without ExPVT-targeted ablation.
Conclusion:
ExPVTs are strongly associated with lower LA voltage and carry independent prognostic value for AF recurrence, with outcomes varying by anatomical location and targeted ablation status. These findings underscore the importance of systematic ExPVT assessment and selective targeting in individualized ablation strategies.
Clinical Trial Registration:
NCT02138695.
